RBC Capital analyst Gregory Renza maintains Amgen (NASDAQ:AMGN) with a Sector Perform and lowers the price target from $268 to $258.
RBC Capital Maintains Sector Perform on Amgen, Lowers Price Target to $258
RBC Capital analyst Gregory Renza maintains Amgen (NASDAQ:AMGN) with a Sector Perform and lowers the price target from $268 to $258.